Back to search

Article

The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.

2022-01-25

Abstract excerpt

<h4>Background: </h4> Many available medicines have been evaluated as potential repurposed treatments for coronavirus disease 2019 (COVID-19). We summarise the registered study landscape for 32 priority pharmacological treatments identified following consultation with external experts of the COVID-19 Clinical Research Coalition. <h4>Methods: </h4>: All eligible trial registry records identified by systematic sear...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
39d4147b-4c2b-53ad-b325-9f5b4096c15c
DOI
10.12688/wellcomeopenres.17284.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.DOI 10.12688/wellcomeopenres.17284.1
Select a neighboring publication to make it the new centre.